Department of Microbiology, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Appl Environ Microbiol. 2012 Jan;78(2):411-9. doi: 10.1128/AEM.06396-11. Epub 2011 Nov 18.
Indole production by Escherichia coli, discovered in the early 20th century, has been used as a diagnostic marker for distinguishing E. coli from other enteric bacteria. By using transcriptional profiling and competition studies with defined mutants, we show that cyclic AMP (cAMP)-regulated indole formation is a major factor that enables E. coli growth in mixed biofilm and planktonic populations with Pseudomonas aeruginosa. Mutants deficient in cAMP production (cyaA) or the cAMP receptor gene (crp), as well as indole production (tnaA), were not competitive in coculture with P. aeruginosa but could be restored to wild-type competitiveness by supplementation with a physiologically relevant indole concentration. E. coli sdiA mutants, which lacked the receptor for both indole and N-acyl-homoserine lactones (AHLs), showed no change in competitive fitness, suggesting that indole acted directly on P. aeruginosa. An E. coli tnaA mutant strain regained wild-type competiveness if grown with P. aeruginosa AHL synthase (rhlI and rhlI lasI) mutants. In contrast to the wild type, P. aeruginosa AHL synthase mutants were unable to degrade indole. Indole produced during mixed-culture growth inhibited pyocyanin production and other AHL-regulated virulence factors in P. aeruginosa. Mixed-culture growth with P. aeruginosa stimulated indole formation in E. coli cpdA, which is unable to regulate cAMP levels, suggesting the potential for mixed-culture gene activation via cAMP. These findings illustrate how indole, an early described feature of E. coli central metabolism, can play a significant role in mixed-culture survival by inhibiting quorum-regulated competition factors in P. aeruginosa.
大肠杆菌产生吲哚,这一发现可追溯到 20 世纪初,它被用作鉴别大肠杆菌与其他肠道细菌的诊断标志物。通过转录谱分析和与定义明确的突变体竞争研究,我们表明,环腺苷酸(cAMP)调控的吲哚形成是使大肠杆菌在与铜绿假单胞菌混合生物膜和浮游种群中生长的主要因素。缺乏 cAMP 产生(cyaA)或 cAMP 受体基因(crp)的突变体,以及吲哚生产(tnaA)的突变体,在与铜绿假单胞菌共培养时没有竞争力,但通过补充生理相关的吲哚浓度可以恢复到野生型竞争力。缺乏吲哚和 N-酰基高丝氨酸内酯(AHLs)受体的大肠杆菌 sdiA 突变体,其竞争适应性没有变化,这表明吲哚直接作用于铜绿假单胞菌。如果与铜绿假单胞菌 AHL 合酶(rhlI 和 rhlI lasI)突变体一起生长,大肠杆菌 tnaA 突变株可以恢复野生型竞争力。与野生型不同的是,铜绿假单胞菌 AHL 合酶突变体无法降解吲哚。混合培养生长过程中产生的吲哚抑制了铜绿假单胞菌的吡咯菌素产生和其他 AHL 调控的毒力因子。与铜绿假单胞菌混合培养刺激了无法调节 cAMP 水平的大肠杆菌 cpdA 中吲哚的形成,这表明通过 cAMP 可能有混合培养基因激活的潜力。这些发现说明了吲哚作为大肠杆菌中心代谢的早期描述特征,如何通过抑制铜绿假单胞菌中群体感应调节的竞争因子,在混合培养物的生存中发挥重要作用。